Skip to content
drillr.ai
Sign up

HOTH

Hoth Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

Also listed · RKTO →
$0.80
−2.22%
Ask drillr

  • Nov 3, 2026, 13:17 UTC

    Hoth Therapeutics, Inc. decided to end its Phase 2a clinical trial of HT-001 early after strong interim efficacy results.

    Source: